About Us
Introduction
NunaBio is a privately-owned specialist DNA development company.
We are engaged in CRO (Contract Research Organizations) and CDMO (Contract Development and Manufacturing Organisation) activities. The company has built a solid reputation for its R&D flexibility and innovative approach to complex and challenging projects.
Expertise
NunaBio’s core expertise is research and development into cell-free DNA synthesis, process optimisation, route design, scale-up and small-scale manufacture for clinical studies.
We take a personal approach when working with our customers.
For all contract services, we will carry out all the necessary research needed for the development of your target products and will communicate the results to you on a regular basis.
Work with us
We work through detail design, integration, and initial testing, repeating this process to optimise the design before verification testing.
Our work is fully documented and a package of data and specifications can be assembled to allow scale up manufacture to start smoothly.
We use enzymatic processes to manufacture DNA.
Not only does this reduce the consumption of reagents, it also eliminates the use of hazardous chemicals and the production of toxic waste associated with other methods.
Our processes support the UK Life Sciences Strategy 2021 aim of escalating biologics development and manufacture to build resilience against future pandemics and we can propel novel therapeutics and diagnostics to clinic, accelerating innovation and improving patients’ lives.
Meet the Team.
Leadership Team
Joe Hedley, PhD, MBA.
CEO
As Co-Founder and CEO, Joe has over 10 years’ experience in novel DNA based biotechnologies. Joe has developed and delivered successful sales strategies, led new business development and partnerships with SMEs, academia, and multi-nationals. Managed and led high profile (£M) and award-winning product developments with associated quality and regulatory requirements. He has also secured and managed £M10’s in UK and EU grants as well as supporting company investment to a number of SMEs.
Eimer Tuite, PhD.
CSO
Eimer is Chief Scientific Officer and Co-Founder of NunaBio. A global authority in molecular electronics, imaging, and DNA-diagnostics, Eimer brings with her a skillset that spans physics, biochemistry, and structural biology.
Andrew Pike, PhD.
CTO
Andrew is Chief Technology Officer and Co-Founder of NunaBio. He has over 40 peer-reviewed publications on synthesising functional DNA-based nanomaterials via enzymatic and solid-phase methods. His academic research focuses on the synthesis, structure, and function of DNA.
Sarah Greenhalgh, LLB.
COO
Sarah is NunaBio’s Chief Operating Officer. Sarah has experience across private and public sectors supporting strategic decisions and commercial operations including project management of clinical, academic and commercial research projects; HR, finance, IT and Health and Safety within QMS environments.
Board of Directors
Colin Mitchell.
Chartered Director
Colin (BVM&S, CertEP, CertVBM, MRCVS) is NunaBio’s Independent Board Chair bringing a wealth of experience as a business owner and manager together with professional qualifications from Institute of Directors and The University of Law.
Alex Buchan, PhD.
Investment Director NorthStar Ventures
Alex makes and manages investments into a wide range of technology businesses in the health-tech and green-tech sectors, often acting as Board Observer or Investment Director.
Alisa Molotova, PhD.
Investment Manager Martlet Capital
Alisa has worked in deep science and technology and supported strategic innovation projects.
Sandy Primrose, PhD.
Non-Exec Director
Sandy has experience in the development and exploitation of new products and processes in the fields of life sciences, diagnostics, medical devices and biopharmaceuticals including the development of appropriate business strategies and troubleshooting product and process development.
Chris Wheatcroft.
Investment Partner, Ascension Ventures
Chris manages a portfolio of tech and fin-tech companies and has successfully fundraised and exited a number of companies within this space.
Gemma Sturt.
Biotech and Health Investor, Pioneer Group
Gemma works at the forefront of venture building and has experience of mentoring pre-spin out and early stage Bio & HealthTech teams.
Our Partners
NunaBio Ltd
The Biosphere
Draymans Way
Newcastle Helix
Newcastle upon Tyne
NE4 5BX
T.+44 (0) 330 2292700
info@nunabio.com
